Robotic vs. Non-Robotic Single-Site Hysterectomy: Marchand Institute’s New Meta-Analysis Provides Clarity on Surgical Outcomes
FOR IMMEDIATE RELEASE
MESA, Ariz. — September 15, 2020
Dr. Marchand is extremely honored that the American Journal of Obstetrics and Gynecology (commonly known as the Gray Journal) has accepted one of his recent studies for publication. The study focuses on salpingectomy, or removal of the fallopian tubes for sterilization and to reduce the risk of ovarian cancer. You can see the article online in the journal at this link: https://www.sciencedirect.com/science/article/abs/pii/S0002937820310681
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###
Related posts
